After raising Rs 40.25 crore by issuing 700,000 equity shares to its promoters Dashtag, Fulford India has utilized Rs. 41 lakh towards business expansion in the quarter ended June 30, 2013. The total amount utilized till June 30, 2013 is Rs. 2.41 crore. The remaining unutilised balance of Rs 37.84 crore will be invested in fixed deposits with banks .
The company has raised the said funds to the tune of Rs 40.25 crore to provide capital in order to permit the company to strengthen its position in the market and act on strategic business growth opportunities.
Fulford (India) is engaged in the business of manufacturing and marketing pharmaceutical consumer products, including cough tablets and herbal ointments, marketed under the trademarks - PEPS and ZAMBUK respectively. It offers medicines for the treatment of allergy and respiratory, arthritis and immunology, cancer therapies, cardiovascular, hepatitis, sun care, etc.
No comments:
Post a Comment